# ChampioNIR® SFA Stent EFS Study

> **NCT03775226** · NA · TERMINATED · sponsor: **Medinol Ltd.** · enrollment: 22 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** ChampioNIR® SFA Stent

## Key facts

- **NCT ID:** NCT03775226
- **Lead sponsor:** Medinol Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-27
- **Primary completion:** 2021-08-26
- **Final completion:** 2023-01-30
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** The study objective was achieved. Patients are no longer being examined or receiving intervention.
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03775226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03775226, "ChampioNIR® SFA Stent EFS Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03775226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*